dc.contributor.author
Rebollo de Grado, Alba
dc.contributor.author
Baena Muñoz, Miguel
dc.contributor.author
Roglans i Ribas, Núria
dc.contributor.author
Alegret i Jordà, Marta
dc.contributor.author
Laguna Egea, Juan Carlos
dc.date.issued
2014-03-07T16:52:53Z
dc.date.issued
2014-03-07T16:52:53Z
dc.date.issued
2012-12-01
dc.date.issued
2014-03-07T16:52:53Z
dc.identifier
https://hdl.handle.net/2445/51004
dc.description.abstract
Introduction and aims. During last few decades, the prevalence of obesity, metabolic syndrome and insulin resistance, among other metabolic disturbances, has raised considerably in many countries worldwide. Environmental factors (diet, physical activity), in tandem with predisposing genetic factors, may be responsible for this trend. Along with an increase in total energy consumption during recent decades, there has also been a shift in the type of nutrients, with an increased consumption of fructose, largely attributable to a greater intake of beverages containing high levels of fructose...
dc.format
application/pdf
dc.publisher
Sociedad Española de Farmacología
dc.relation
Reproducció del document publicat a: http://socesfar.com/revista-aft/numeros-revista-aft.html
dc.relation
Actualidad en Farmacología y Terapéutica, 2012, vol. 10, num. 4, p. 289-291
dc.rights
(c) Fundación Teófilo Hernando / Sociedad Española de Farmacología, 2012
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject
Malalties del fetge
dc.subject
Liver diseases
dc.title
Fructose induces synthesis and reduces oxidation of liver fatty acids through ChREBP activation
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion